Zacks98d agoneutral
Why Flowco's Valiant Acquisition Matters for Future GrowthFLOC's $200M Valiant deal adds ESPs to its lift lineup, expanding Permian reach and enabling end-to-end support as wells mature.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
340last 24h
2355last 7d
426● bullish (7d)
219● bearish (7d)
202publishers
Zacks99d agoneutral
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/YCLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
Zacks102d agobullish
Chevron Q1 Earnings Beat Estimates, Revenues Increase Y/YCVX distributes $6 billion to its shareholders, including $2.5 billion in buybacks and $3.5 billion in dividends during the first quarter
Zacks102d agoneutral
NOV Q1 Earnings Miss Estimates, Revenues Beat, Decrease Y/YNOV Q1 earnings miss estimates as Middle East disruptions hit operations, while revenues edge past expectations despite a year-over-year decline.
MarketBeat102d agoneutral
Core Laboratories Q1 Earnings Call HighlightsCore Laboratories (NYSE:CLB) executives said first-quarter 2026 results were significantly affected by geopolitical and weather-related disruptions, with the escalation of military conflict in the Middle East creating meaningful project delays, halting some hydrocarbon production, and disrupting mar